International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. - Wikidata - thesis-toulmin - TriplyDB

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.

http://www.wikidata.org/entity/Q35164084

about

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen Preoperative chemotherapy for women with operable breast cancer Preoperative chemotherapy for women with operable breast cancer Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer.Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.New Therapeutic Options for Breast Cancer during Pregnancy.Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy.Current and future trends in magnetic resonance imaging assessments of the response of breast tumors to neoadjuvant chemotherapy.Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.Geometrical features assessment of liver's tumor with application of artificial neural network evolved by imperialist competitive algorithm.Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.Trastuzumab-based combination therapy for breast cancer.Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer Texture analysis on MR images helps predicting non-response to NAC in breast cancer Correlation between the proportion of breast volume involved by locally advanced tumors and invasion of the skin and posterior structures.MRI in the detection and management of breast cancer.Controversies in breast cancer: adjuvant and neoadjuvant therapy.Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy The effect of accompanying in situ ductal carcinoma on accuracy of measuring malignant breast tumor size using B-mode ultrasonography and real-time sonoelastography Docetaxel in the treatment of breast cancer: current experience and future prospects.Breast Cancer: State of the Art and New Findings.Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer.Antiangiogenic therapies in early-stage breast cancer.Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.The accuracy of (18)F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review.Histologic Grade and Decrease in Tumor Dimensions Affect Axillary Lymph Node Status after Neoadjuvant Chemotherapy in Breast Cancer Patients Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study.Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)Triple-negative breast cancer exhibits a favorable response to neoadjuvant chemotherapy independent of the expression of topoisomerase IIα.Evaluation of biological pathways involved in chemotherapy response in breast cancer.Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy.State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments.Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patients Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response.Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

P2860

Q21092375-FE6AA775-FDAA-49D1-B96D-60905682E923 Q24245281-DB9C545F-013F-4D21-8E89-6ED722CCBAB5 Q24246444-C684066F-9AAB-48D1-AB7B-465437645D38 Q28235277-389F4553-FF46-4D99-877F-3C07EA14599D Q30477571-1059036D-716E-43A7-8CB1-3C825FA23399 Q33304691-45763F7B-1EB7-4D80-9CC3-09F988A067D6 Q33374977-0EBFCE7B-85BD-4370-8968-10551CEB7788 Q34051790-F2ACE15F-F9FB-4EC4-9019-3643F616CE14 Q34096331-3FF65AEC-D98D-4012-83D5-6DD5D3AA2AB3 Q34145424-022EADAC-E9FB-4701-8591-D91E2D1EC928 Q34189855-875C9F9C-C4AA-4D52-8FC0-37337FB1026C Q34475469-2DCCEBE5-0580-4C1A-BEAF-657058CCCCE9 Q35093766-C32A103F-FC36-4534-913A-55CDC96E7743 Q35553994-DC5DF2AC-BA43-4679-8C38-A9157B490F10 Q35605856-28CD5783-D652-4FCB-ABF8-145F3AFA7ABD Q35609686-EFB486D3-8F8D-4625-A5DD-8444A2647A6C Q35657487-FBC370F8-904E-440F-AB3F-8A761A417506 Q35737991-9823BD24-AFC7-4A2D-8808-80E5C6C9628E Q35845356-D96971CD-7DE8-454C-BF9D-DC7D08919F55 Q36118389-253D3936-65B4-4401-BEA6-B9A9AC4E4493 Q36163952-07888284-1CD3-47C9-8703-75D33274EB70 Q36187097-2957902B-C20B-4CBD-8118-5457775CFA44 Q36231005-78664746-E68B-4F43-ABBD-0496E8EB28D7 Q36235546-8786A505-C9AD-465F-B9F2-4B9B1565F707 Q36295112-D2EE389C-A58F-4E21-88B3-C220D57D501E Q36303851-91374F03-09DE-483E-A7BA-B1820CBED5CB Q36318210-B4A66207-4F7F-41C9-B96A-A4A283665507 Q36324120-A4923F03-C706-4B59-B6D0-206A51E1F292 Q36364739-BF39CC34-E4B1-4AB6-BA7D-156EE3B43A02 Q36441562-978266C1-F300-47E9-83DC-E1CDE1AA2841 Q36615222-E0F58C91-70B4-4361-993C-4B023CC5ED36 Q36615310-69BB06AF-ED37-404A-87EF-E3E2E09F1A11 Q36640582-855E8159-1946-4913-AD80-87804E9646F9 Q36678725-5F36AC4F-B2B3-47FA-A50A-894D308FC2D7 Q37241048-C11748DD-8110-4B09-82FF-A78A9D8F853B Q37244111-F51F82BA-0475-4B3D-B1C5-A8EEF31C026E Q37244377-2220A817-A111-41DC-911B-E8BD8944C349 Q37385321-FD8299E2-D0AB-4229-97D6-D47147110C6D Q37408139-557DACBA-CC40-4904-AE8E-B3867FA5923D Q37424040-437CDC1E-DAA6-4E50-98B5-540EBAF06A92

P2860

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.

http://www.wikidata.org/entity/Q35164084

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

International expert panel on ...... r: review and recommendations.

@ast

International expert panel on ...... r: review and recommendations.

@en

type

label

International expert panel on ...... r: review and recommendations.

@ast

International expert panel on ...... r: review and recommendations.

@en

prefLabel

International expert panel on ...... r: review and recommendations.

@ast

International expert panel on ...... r: review and recommendations.

@en

P1433

Q35164084-FC2277D1-1E18-4F81-A595-F6A500AD3AEF

P1476

Q35164084-49CF499B-E962-4D7D-A35B-6F869A266E3A

P2093

Q35164084-03ACD39B-A48A-4809-8DCA-120FF023CAC0

Q35164084-1E297855-BA98-47B5-9F2E-1EEF1CCACA31

Q35164084-479A6FE9-EDBD-4570-B3D0-1F9EA41CD82B

Q35164084-517BDECD-BD17-4FBD-A313-3901612CBDEA

Q35164084-6B19E47D-8CBA-48D8-B9FF-08FAC5BDC7ED

Q35164084-7273A606-5DEC-46CC-A2C4-A648641EBC61

Q35164084-798FB005-3CD6-42F5-BDB0-40843D4B0AFC

Q35164084-831414CA-C459-4FA7-B750-B1D662888BD6

Q35164084-870DFF14-4B8F-4843-B441-1A1387C421DD

Q35164084-AF43D95C-46E8-41D2-8B8C-EC9C05002B75

P304

Q35164084-BDC53848-1504-4F8F-8E89-589B511CF994

P31

Q35164084-A039E001-AA43-48C2-8676-0C82135A2CF0

P356

Q35164084-088B532F-86EC-4DFB-908B-44DB30ECC513

P407

Q35164084-251A8934-3CF3-4557-A7DC-B6459FFEDE65

P433

Q35164084-222564DE-1224-4F8A-BDFB-15A7D27B3342

P478

Q35164084-AA63C51A-C11E-4314-AE6E-47DD45E15CD4

P50

Q35164084-0AB6C111-516E-456F-B010-54D1F38FDF67

Q35164084-2E9C3CA1-9283-4B2C-BE45-FD33A0E6B5C4

Q35164084-75FCE181-7449-4CF4-8785-2D667D9CF7F4

Q35164084-80A74229-D76E-4F31-8CCF-9F2E794A4CC6

P577

Q35164084-910FA278-8CB9-4F4D-8EC1-3EBD2515D896

P698

Q35164084-88BF3A13-3700-4175-B085-C4F69920DAB1

P356

JCO.2003.01.136

P1433

Journal of Clinical Oncology

P1476

International expert panel on ...... r: review and recommendations.

@en

P2093

Anthony Howell

http://www.w3.org/2001/XMLSchema#string

Augustinos H Tulusan

http://www.w3.org/2001/XMLSchema#string

Hans-Jörg Senn

http://www.w3.org/2001/XMLSchema#string

Hans-Peter Sinn

http://www.w3.org/2001/XMLSchema#string

Jens-Uwe Blohmer

http://www.w3.org/2001/XMLSchema#string

Luca Gianni

http://www.w3.org/2001/XMLSchema#string

Manfred Kaufmann

http://www.w3.org/2001/XMLSchema#string

Philippe Beuzeboc

http://www.w3.org/2001/XMLSchema#string

Rainer Souchon

http://www.w3.org/2001/XMLSchema#string

Rolf Sittek

http://www.w3.org/2001/XMLSchema#string

P304

2600-2608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2003.01.136

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Gunter von Minckwitz

Wolfgang Eiermann

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12829681

http://www.w3.org/2001/XMLSchema#string